Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!   Twitter
Follow us on Instagram!  Instagram 
Add us to your circle in Google+!


Subscribe to our channel on YouTube!  YouTube  




Colorado Public Radio Features Story on Promising VX-770 Drug

December 2, 2008

The Cystic Fibrosis Foundation is making it possible to develop a promising new treatment for CF by funding pharmaceutical research, according to a report today heard on Colorado Public Radio. 

The story features an interview with Frank Accurso, M.D., director of the CF care center at the Children’s Hospital in Denver, Colo. A cystic fibrosis drug that could address the root cause of CF is moving forward because the Foundation made a significant investment of nearly $80 million, he said.

Accurso explained further: “Most drugs companies are interested in diabetes or hypertension or heart disease or cancer conditions that afflict millions of people.”

Accurso is the principal investigator of clinical trials for a potential CF drug known as VX-770. The drug is being developed and tested by Vertex Pharmaceuticals Incorporated with support from the CF Foundation.

“We have some very, very exciting possibilities, “ said Accurso. “At least one (drug) so far looks very, very good in trials with patients with individuals with cystic fibrosis.”

In October, the CF Foundation announced that VX-770 showed positive results in a 28-day, Phase 2 clinical trial.

Listen to the full story.


The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.